Comparative Evaluation of LaxaPlus Barij® and Polyethylene Glycol in Pediatric Functional Constipation

Objective

This study aimed to compare the effectiveness of LaxaPlus Barij® and polyethylene glycol (4000) in treating functional constipation in children aged 2-15 years.

Methods

A randomized clinical trial was conducted with 60 children suffering from functional constipation, divided into two groups. One group received LaxaPlus Barij®, and the other received polyethylene glycol (4000) for 8 weeks. Data analysis was performed using SPSS software, with a significance level of <0.05.

Findings

The study found no significant difference in demographic characteristics between the two groups. Both treatments significantly improved stool consistency and the number of bowel movements. However, the LaxaPlus Barij® group showed a higher frequency of bowel movements and greater reduction in pain intensity and abdominal pain compared to the polyethylene glycol group.

Conclusion

Both LaxaPlus Barij® and polyethylene glycol (4000) are effective in treating functional constipation in children. LaxaPlus Barij® was more effective in increasing the frequency of bowel movements and reducing pain intensity and abdominal pain after 8 weeks of treatment. However, there was no significant difference in satisfaction levels between the two groups.

Keywords

Child, constipation, LaxaPlus Barij®, polyethylene glycol